Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy in early breast cancer (EBC) - a German health economic analysis

Lux, M. P. and Benedict, A. and Buchholz, S. and Woeckel, A. and Harbeck, N. and Kreienberg, R. and Kaufmann, M. and Beckmann, M. W. and Jonat, W. and Hadji, P. and Distler, W. and Raab, G. and Tesch, H. and Weyers, G. and Schneeweiss, A. and Possinger, K. (2009) Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy in early breast cancer (EBC) - a German health economic analysis. In: 31st Annual San Antonio Breast Cancer Symposium, December 10-14, 2008, San Antonio, TX.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Petra Gürster
Date Deposited: 27 Oct 2022 08:34
Last Modified: 27 Oct 2022 08:44
URI: https://pred.uni-regensburg.de/id/eprint/29576

Actions (login required)

View Item View Item